Ascend Laboratories, LLC is recalling 8,568 bottles of Amlodipine and Olmesartan Medoxomil Tablets (5 mg/ 40 mg) because the medication failed dissolution testing. This defect means the drug may not break down properly in the body, which can prevent the active ingredients from working effectively to manage blood pressure. If you are taking this medication, you should contact your doctor or pharmacist to discuss your treatment options and verify if your bottle is part of the recall.
Low dissolution results mean the medication may not be fully absorbed by the body, potentially leading to poorly controlled blood pressure and an increased risk of related cardiovascular issues. No incidents or injuries have been reported to date.
You have 2 options:
Manufactured by Alkem Laboratories Ltd., India; Distributed by Ascend Laboratories, LLC, Parsippany, NJ.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.